General MedicationsINJECTIONGeneric

DOXORUBICIN HYDROCHLORIDE

Standard Dose

10MG/VIAL

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview DOXORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 200170 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 10MG/VIAL Sponsor MYLAN LABS LTD Submission history Latest submission status date: 2014-11-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOXORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 200170 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 10MG/VIAL Sponsor MYLAN LABS LTD Submission history Latest submission status date: 2014-11-03 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.